Understanding Nemaline Myopathy Over Time (Spain)
Part of Bones, joints & muscles, Brain & nervous system clinical trials.
This study follows people with nemaline myopathy over time to better understand how the disease progresses. It helps researchers learn more about the condition and plan future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed or suspected diagnosis of nemaline myopathy based on genetic testing or a muscle biopsy.
- Genetic mutation, if known, is in one of the following genes: ACTA1, NEB, TPM2, TPM3, KBTBD13, CFL2, KLHL40, KLHL41, LMOD3, MYPN, TNNT1, or TNNT3.
- You (or your legal guardian) must sign a consent form agreeing to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with LAMA2-related muscular dystrophy over time to better understand the condition. It may help with future treatments by learning more about how the disease progresses.
This study follows people with nemaline myopathy over time to understand how the condition progresses naturally. It does not test a treatment, so it helps researchers learn more about the disease.
This study creates a network for children with nemaline myopathy (a muscle weakness condition). It aims to better understand the condition and prepare for future treatments.
This study follows patients with congenital myopathies to understand how their muscles get tired over time. It may help develop better treatments.
This study follows people with a rare genetic muscle condition called TNNT1 myopathy over time. Researchers will track how the disease progresses to better understand it and help plan future treatments.
This study follows people with LAMA2-related muscular dystrophy or SELENON-related myopathy over 5 years to understand how the condition changes over time. It may help you by tracking your disease progression and contributing to future research.
Hear when a new Nemaline Myopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.